Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Kexing Pharmaceutical Co., Ltd.

Clinical trials sponsored by Shenzhen Kexing Pharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drug GB10 enters early human testing for wet AMD Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New injection aims to stop cancer wasting

Disease control Recruiting now

This early-stage trial tests a new drug called GB18 in 36 healthy adults to see if it is safe and how the body handles it. The drug is designed to treat cancer cachexia, a condition where cancer patients lose weight and muscle. Participants receive a single injection of GB18 or a…

Phase 1 • Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC